How to Interpret Parasite Persistence and Transmission to Mosquitoes After Antimalarial Treatment in Kenya?

Clin Infect Dis. 2023 Feb 8;76(3):555-557. doi: 10.1093/cid/ciac740.

Authors

Sara Lynn Blanken¹, Harouna Dit Massire Soumare², Chiara Andolina¹, Kjerstin Lanke¹, Teun Bousema^{1

3}

Affiliations

¹ Department of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
² Medical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
³ Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

PMID: 36069392
DOI: 10.1093/cid/ciac740

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Animals
Antimalarials* / therapeutic use
Culicidae*
Humans
Kenya / epidemiology
Malaria, Falciparum* / drug therapy
Malaria, Falciparum* / epidemiology
Malaria, Falciparum* / parasitology
Mosquito Vectors
Parasites*
Plasmodium falciparum

Substances

Antimalarials